H-L-Asp(tBu)-OtBu*HCl

H-L-Asp(tBu)-OtBu*HCl is a protected L-aspartic acid derivative in which the side-chain carboxyl group is masked as a tert-butyl ester (Asp(tBu)), while the α-carboxyl group is present as a tert-butyl ester hydrochloride salt (OtBu*HCl). The molecule therefore contains a stereodefined α-amino acid core with a chiral center at the α-carbon, and it bears two ester-protected carboxyl functionalities that can be selectively deprotected under acid conditions to regenerate the corresponding free carboxylic acids. The hydrochloride salt form improves handling of the protected amine during peptide coupling workflows by providing a defined protonation state. The tert-butyl ester protecting groups create a controlled reactivity profile that supports peptide building-block preparation, downstream derivatization of side-chain functionality, and chiral intermediate use in amino acid chemistry.

1. Peptide Synthesis

H-L-Asp(tBu)-OtBu*HCl is used in peptide building block preparation where aspartate side-chain protection is required to prevent undesired side reactions during amide bond formation. The Asp(tBu) side-chain tert-butyl ester and the α-OtBu group provide orthogonal protection to the carboxyl termini relative to the amine coupling site, enabling stepwise construction of Asp-containing sequences. The hydrochloride salt form can be applied in protected amino acid workflows to support consistent coupling chemistry and minimize amine deprotonation variability. Deprotection can later regenerate the native aspartic acid functionality for incorporation into longer peptides and for producing peptide intermediates used in solid-phase or solution-phase synthesis. The protected carboxyl pattern also aligns with standard peptide synthesis strategies that require controlled exposure of acidic residues.

2. Amino Acid Derivatization

H-L-Asp(tBu)-OtBu*HCl serves as a chiral amino acid ester intermediate for derivatization routes that convert protected carboxyl groups into functional handles for further synthetic elaboration. The tert-butyl ester groups can be transformed into free acids to enable subsequent coupling, salt formation, or selective functional group interconversions at the α- and side-chain positions. The stereochemical integrity of the L-aspartate scaffold supports stereospecific downstream chemistry, including formation of amide, ester, or activated acid derivatives that retain the native spatial arrangement of the carboxylate-bearing side chain. The hydrochloride salt form can facilitate controlled reactivity during intermediate isolation and conversion to activated species for fine chemical synthesis. This makes the compound suitable for generating aspartate-based intermediates used in peptide analogs, linker chemistries, and structure-defined building blocks.

3. Peptidomimetics And SAR

H-L-Asp(tBu)-OtBu*HCl is applied in peptidomimetic and SAR studies where protected aspartate geometry is needed to construct constrained or modified analogs. The protected side-chain carboxyl group allows incorporation of aspartate-like acidic functionality into non-native scaffolds without premature deprotection during multistep synthesis. The α-amino acid ester framework supports conversion into amide-linked motifs, while later acid deprotection can restore the carboxylate for analogs that require defined hydrogen-bonding and ionic interaction patterns. The stereodefined L configuration supports consistent spatial presentation of the acidic side chain, which is relevant for structure-activity relationship investigations that compare analog series. The compound thus functions as a practical chiral precursor for generating aspartate-containing molecular scaffolds used in medicinal chemistry and biochemical research.

4. Chemical Manufacturing Intermediate

H-L-Asp(tBu)-OtBu*HCl is suitable for process chemistry intermediate preparation in industrial fine chemical production where protected amino acid esters are required to manage reactivity and impurity control. The tert-butyl ester protecting groups provide a stable, acid-labile masking strategy for carboxyl functionalities, supporting manufacturing routes that separate coupling steps from final deprotection or functionalization steps. The hydrochloride salt form can improve handling and reproducibility of the amino acid derivative during scale-up operations that depend on consistent protonation and solubility behavior. The defined stereochemistry of the L-aspartate core supports downstream generation of consistent batches of Asp-containing intermediates for peptide-manufacturing pipelines and specialty chemical synthesis. The compound's protection pattern also supports controlled downstream conversion into activated acids or coupling-ready derivatives for producing larger biomolecule fragments.

5. Bioconjugation Linkers

H-L-Asp(tBu)-OtBu*HCl is used in chemical biology workflows to prepare aspartate-based linkers and conjugation intermediates that require protected carboxyl groups during assembly. The Asp(tBu) side-chain ester can be deprotected to yield a free carboxylate suitable for subsequent coupling to amines, hydrazides, or other nucleophiles, while the α-carboxyl functionality can be similarly unmasked when a defined attachment point is required. The stereodefined amino acid backbone supports incorporation into conjugates that preserve the spatial arrangement of acidic groups used for molecular recognition or solubility tuning. The hydrochloride salt form supports predictable amine protonation during intermediate handling prior to activation chemistry. The resulting aspartate-derived conjugation building blocks can be applied in constructing labeled peptides, affinity reagents, and functional biomolecule fragments for analytical and biochemical studies.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef

3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review